Kedrion Biopharma – Gödöllö (Hungary)
Automation project for new production unit expansions at the Gödöllő plant in Hungary. Development of the new applications and commissioning of the new production lines.

Kedrion produces and distributes human plasma-derived medicinal products used to treat and prevent rare and debilitating diseases and disorders. It now has a market presence in about 100 countries in Asia, Europe, and North and South America. With a plasma fractionation capacity of 600,000 liters and a dedicated workforce of around 200 people, the Gödöllő plant specializes in the production of intermediates for our life-saving Immunoglobulins and Human Albumin.